Stock data

進階 (3118)

進階 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$63.72M, down 9.2% from a year earlier. EPS over the last four quarters totals NT$2.35.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 進階 in Insightr